126 related articles for article (PubMed ID: 23279907)
1. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.
Filizola M; Harris DL; Loew GH
J Biomol Struct Dyn; 2000 Apr; 17(5):769-78. PubMed ID: 10798522
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
Sindhu T; Srinivasan P
J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
Vijayan RS; Ghoshal N
J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
[TBL] [Abstract][Full Text] [Related]
5. Pseudoreceptor models and 3D-QSAR for imidazobenzodiazepines at GABA A/BzR subtypes alphaxbeta3gamma2 [x = 1-3, 5, and 6] via flexible atom receptor model.
Lu A; Zhou J
J Chem Inf Comput Sci; 2004; 44(3):1130-6. PubMed ID: 15154782
[TBL] [Abstract][Full Text] [Related]
6. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
Reddy KK; Singh SK
Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
[TBL] [Abstract][Full Text] [Related]
7. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
[TBL] [Abstract][Full Text] [Related]
8. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
10. Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation.
Harris DL; DeLorey TM; He X; Cook JM; Loew GH
Eur J Pharmacol; 2000 Aug; 401(3):271-87. PubMed ID: 10936485
[TBL] [Abstract][Full Text] [Related]
11. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.
Yang J; Hu J; Zhang G; Qin L; Wen H; Tang Y
J Mol Model; 2021 Aug; 27(9):260. PubMed ID: 34432157
[TBL] [Abstract][Full Text] [Related]
13. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
Tripuraneni NS; Azam MA
J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
[TBL] [Abstract][Full Text] [Related]
14. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
Malla P; Kumar R; Kumar M
Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
[TBL] [Abstract][Full Text] [Related]
15. Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies.
Contreras-Romo MC; Martínez-Archundia M; Deeb O; Slusarz MJ; Ramírez-Salinas G; Garduño-Juárez R; Quintanar-Stephano A; Ramírez-Galicia G; Correa-Basurto J
Chem Biol Drug Des; 2014 Feb; 83(2):207-23. PubMed ID: 24010681
[TBL] [Abstract][Full Text] [Related]
16. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
17. 5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
Oberdorf C; Schmidt TJ; Wünsch B
Eur J Med Chem; 2010 Jul; 45(7):3116-24. PubMed ID: 20427100
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore modeling, comprehensive 3D-QSAR, and binding mode analysis of TGR5 agonists.
Sindhu T; Srinivasan P
J Recept Signal Transduct Res; 2017 Apr; 37(2):109-123. PubMed ID: 27267434
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
Reddy KK; Singh SK; Tripathi SK; Selvaraj C
SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
